2invest AG

2INV

DE000A3H3L44

Investment Holding Companies

Market Closed - Xetra Other stock markets 11:35:30 2025-12-09 am EST			5-day change	1st Jan Change
11.70 ^EUR	0.00%		+1.74%	-0.85%

Aug. 07	2invest AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
Jun. 15	2invest AG's Equity Buyback announced on June 17, 2020, has expired.	CI

2invest AG Reports Earnings Results for the Full Year Ended December 31, 2023

Published on 04/23/2024

S&P Capital IQ

2invest AG

0.00%

2invest AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net income was EUR 1.58 million compared to net loss of EUR 21.03 million a year ago.

Latest news about 2invest AG

Aug. 07	2invest AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
Jun. 15	2invest AG's Equity Buyback announced on June 17, 2020, has expired.	CI
Feb. 27	Leucid Bio Ltd announced that it has received £7.2 million in funding from Epidarex Capital, 2invest AG	CI
Feb. 26	2invest AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-08-04	2invest AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-28	Elevage Medical Technologies and M&G Investment Management Limited signed term sheet to acquire an 15% stake in 4basebio PLC from entities belonging to Deutsche Balaton AG, certain management and directors of 4basebio and 2invest AG for £29.39 million.	CI
24-04-23	2invest AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-27	Geopacific Resources Extends Maturity Date of Bearer Bonds	MT
24-01-01	Geopacific Resources Secures Further AU$1.8 Million Funding for Woodlark Gold Project; Shares Down 5%	MT
23-08-16	2invest AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-05	2invest AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-08-10	2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-04-20	2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-03-22	Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from Claris Ventures SGR SpA, 2invest AG	CI
22-03-15	Kither Biotech s.r.l. announced that it has received €18.5 million in funding from a group of investors	CI
21-10-20	Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Capital, Vulpes Investment Management Private Ltd, 2invest AG, British Business Investments Ltd., Sofinnova Partners SAS	CI
21-09-24	2Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-02-10	4Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020	CI
21-01-19	4basebio AG cancelled the acquisition of KROMI Logistik AG.	CI
20-12-30	4basebio AG Announces Board Changes	CI
20-12-07	4basebio AG completed the spin-off of Genomics and DNA manufacturing business.	CI
20-12-02	4basebio AG Announces Board Changes	CI
20-11-19	4Basebio Ag Reports Earnings Results for the Nine Months Ended September 30, 2020	CI
20-08-16	The Board of Directors of 4basebio AG announced the spin-off of unknown majority stake in Genomics and DNA manufacturing business.	CI
20-08-13	4basebio AG, H1 2020 Earnings Call, Aug 13, 2020

Chart 2invest AG

Duration

Period

2INV: Dynamic Chart

Company Profile

2Invest AG, is formerly known as 4Basebio AG, is a Germany-based investment company. The Company acquires, holds, manages and sells investments in corporations and partnerships, particularly in the biotechnology, life science and IT sectors as well as in the natural resources sector both domestically and abroad.

Employees

Sector

Investment Holding Companies

More about the company